Analgesics in Belgium

Date: October 11, 2017
Pages: 38
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AA805F233A7EN
Leaflet:

Download PDF Leaflet

Manufacturers fear the category could face other years (almost) without pathologies as in 2017. In terms of epidemiology, there was absolutely no peak of flu from January to March, in contrast with the same period in 2016. Given that Belgians usually over-consume systemic analgesics at the first sign of cold or flu symptoms, the increasingly uncertain climatic conditions pose a serious threat for the category.

Euromonitor International's Analgesics in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Bigger Packages and Forte Formats Hardly Offset the Climatic Impact and Lack of Self-medication
OTC Analgesics Get A Little Help From the Disaffection for Rx Analgesics
Sports and Demand for Convenience Likely To Boost Sales of Topical Analgesics
Competitive Landscape
Challengers' Offensive Slows Down in 2017
Lack of Real Innovation and Advertising Leaves the Field Clear for Generics
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
2017 Is Almost A Year To Forget for Consumer Health
Manufacturers Are Playing A Cat-and-mouse Game With Local and European Authorities
Ethical Multinationals Find It Difficult To Face the Aggressiveness of Local Players
Chemists/pharmacies Largely Dominate But Lose Ground
Possible Soft Blow for Consumer Health
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Definitions
Sources
  Summary 2 Research Sources
Executive Summary
2017 Is Almost A Year To Forget for Consumer Health
Manufacturers Are Playing A Cat-and-mouse Game With Local and European Authorities
Ethical Multinationals Find It Difficult To Face the Aggressiveness of Local Players
Chemists/pharmacies Largely Dominate But Lose Ground
Possible Soft Blow for Consumer Health
Market Indicators
  Table 19 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 20 Life Expectancy at Birth 2012-2017
Market Data
  Table 21 Sales of Consumer Health by Category: Value 2012-2017
  Table 22 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 23 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 24 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 25 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 26 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 27 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 28 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 29 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 3 OTC: Switches 2016-2017
Definitions
Sources
  Summary 4 Research Sources
Skip to top


OTC Pharmaceuticals in Belgium US$ 350.00 Sep, 2014 · 38 pages
Adult Mouth Care in Belgium US$ 990.00 Sep, 2016 · 26 pages
Calming and Sleeping in Belgium US$ 990.00 Jun, 2015 · 24 pages

Ask Your Question

Analgesics in Belgium
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: